CNS Metastasis Meeting - Friday, February 26, 2027
Note that the programme is subject to change and will be continuously updated.
All times are in Central European Summer Time (CEST).
09:15-09:30 Welcome & Introduction
09:30-11:00
The brain metastatic cascade: biological concepts of CNS colonisation
Joan Massagué, United States
Next-generation molecular neuropathology
Adelheid Wöhrer, Austria
Molecular imaging: visualising biology to guide clinics
Antoine Verger, France
Abstract Presentations: Basic/Translational Science
11:00-11:30 Coffee Break
11:30-13:00
Characterising and targeting the invasive fronts of brain metastases
Tobias Pukrop, Germany
Neurosurgery: new tools to address invasive front and extent of resection
Johnny Duerinck, Belgium
Radiotherapy: expanding role of stereotactic radiosurgery
Giuseppe Minniti, Italy
Combining neurosurgery and radiotherapy: results from the BRAINSTART Registry on intraoperative radiotherapy for brain metastases
Matthias Schneider, Germany
13:00-14:00 Lunch break
14:00-15:30
Understanding therapy resistance to small molecule inhibitors
Céleste Lebbe, France
Resistance to immunotherapy and strategies to tackle it through the microenvironment
Johanna Joyce, Switzerland
ADCs and bispecific antibodies
Lizza Hendriks, Netherlands
Pro-Contra: Pharmacotherapy first vs. Radiotherapy first
Pro: Evangelia Razis, Greece
Contra: Tomáš Kazda, Czech Republic
15:30-16:00 Coffee Break
16:00-17:30
Neuronal crosstalk and its clinical implications
Frank Winkler, Germany
Theranostics: new kid on the block?
Nathalie Albert, Germany
Predicting the risk for developing brain metastases: from biology to clinic
Gelareh Zadeh, United States